ARCHIVES

Includes January Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 05 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

January 15, 1999

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993

Clinical Practice Guidelines Don’t Meet IOM Standards

June 26, 2013

Genentech’s Ferrara Selected for GM Award.

June 23, 2006